Annals of Oncology 14:1335-1337, 2003
© 2003 European Society for Medical Oncology
Editorial |
ESMO takes a stand on supportive and palliative care
1 Medical Oncology and Palliative Medicine Service, Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel; 2 Sheba Medical Center, Tel Aviv University Medical School, Israel; 3 Methaxa Cancer Center, Piraeus, Greece; 4 Maurizio Tonato, Policlinico Divisione Oncologia Medica, Perugia; Marco Maltoni, Pierantoni Hospital Department of Medical Oncology, Forlì, Italy; K. Winand Lange, Johanniter-Krankenhaus Rheinhausen, Duisburg; Herbert Kappauf, Institut für Medizinische Onkologie, Nürnberg; Marianne Kloke, Universitätsklinikum Essen, Essen, Germany; Alexandru-Calin Grigorescu, Oncologic Institute of Bucharest, Bucarest, Romania; Sergei Tjulandin, Cancer Research Center, Moscow; Vladimir Bryuzgin, Cancer Research Center, Moscow, Russia; Piotr Siedlecki, Marie Skledowska-Curie Institute Cancer Center, Warszawa, Poland; 4Kaija Holli, University Hospital Dept of Oncology, Tampere, Finland; Dirk Schrijvers, Middelheim Hospital in Belgium, Antwerp, Belgium; Özgür Özyilkan; Baskent University Faculty of Medicine, Ankara, Turkey; Martin Chasen, Richard Eek Sandton Oncology Centre, Pretoria, South Africa; Maria Wagnerova, University Teaching Hospital, Kosice, Slovak Republic; Janos Szanto, Debrecen Medical University, Debrecen, Hungary; and Joao Oliveira, Istituto Portugues de Oncologia, Losboa Codex, Portugal
*E-mail: chernyn@netvision.net.il
| The first 150 words of the full text of this article appear below. |
Traditionally, the study and practice of medical oncology has focused on the development and implementation of primary anti-cancer therapies. By virtue of these endeavors, along with measures to provide for early diagnosis, substantial improvements in long- and short-term survival have been achieved for a number of cancers such as the germ cell tumors, lymphomas, early stage breast and colorectal cancer, and the leukemias. More sobering, however, are the observations that the cure rate for cancer remains at <50% and that cancer continues to account for >25% of all adult deaths [1]. Many patients are not cured, and for them the issues regarding the quality of their remaining time is critical, irrespective of the clinical course of their illness or the duration of survival.
More than 10 years have passed since the report of the expert committee of the World Health Organization (WHO) on cancer pain and palliative care,
Policy 1: the role of the oncologist in the provision of supportive and palliative care
Policy 2: ESMO policy regarding the supportive and palliative care training for medical oncologists
Policy 3: ESMO policy regarding minimal standards for the provision of supportive and palliative care by cancer centers
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. I. Cherny, A. P. Abernethy, F. Strasser, R. Sapir, D. Currow, and S. Y. Zafar Improving the Methodologic and Ethical Validity of Best Supportive Care Studies in Oncology: Lessons From a Systematic Review J. Clin. Oncol., November 10, 2009; 27(32): 5476 - 5486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Cherny, R. Catane, D. Schrijvers, M. Kloke, and F. Strasser European Society for Medical Oncology (ESMO) Program for the Integration of Oncology and Palliative Care: a 5-year review of the Designated Centers' incentive program Ann. Onc., August 4, 2009; (2009) mdp318v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Von Roenn, F. Strasser, and C. F. von Gunten Update on the Integration of Palliative Care into Cancer Care ASCO Educational Book, January 1, 2009; 2009(1): 590 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Maltoni Opioids, pain, and fear Ann. Onc., January 1, 2008; 19(1): 5 - 7. [Full Text] [PDF]
|
|
|
|
|
|
E Bajetta, A Gevorgyan, and H Mellstedt National integration of European standards Ann. Onc., June 1, 2007; 18(6): 969 - 970. [Full Text] [PDF]
|
|
|
|
|
|
N. I. Cherny, R. Catane, and P. A. Kosmidis Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering Ann. Onc., June 1, 2006; 17(6): 885 - 887. [Full Text] [PDF]
|
|
|
|
|
|
B. Gagnon, N. E. Mayo, C. Laurin, J. A. Hanley, and N. McDonald Identification in Administrative Databases of Women Dying of Breast Cancer J. Clin. Oncol., February 20, 2006; 24(6): 856 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kosmidis, H. Ludwig, and H. Mellstedt ESMO at 30: Mission ongoing Ann. Onc., September 1, 2005; 16(9): 1411 - 1412. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tassinari, B. Poggi, M. Fantini, S. V. Nicoletti, and S. Sartori Quality of care at the end of life: how far are we from reaching a comprehensive solution to the problem? Palliative Medicine, July 1, 2005; 19(5): 434 - 435. [PDF]
|
|
|
|
|
|
H. Ludwig A Foundation for the future Ann. Onc., January 1, 2005; 16(1): 3 - 3. [Full Text] [PDF]
|
|